S M Verstappen

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. ncbi request reprint The Utrecht experience with different treatment strategies in early rheumatoid arthritis
    S M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Clin Exp Rheumatol 21:S165-8. 2003
  2. pmc Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands
    Arthritis Res Ther 8:R31. 2006
  3. pmc Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:1754-60. 2005
  4. ncbi request reprint Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Rheumatology (Oxford) 44:202-6. 2005
  5. pmc Determinants of direct costs in Dutch rheumatoid arthritis patients
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 63:817-24. 2004
  6. ncbi request reprint Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    Arthritis Rheum 51:488-97. 2004
  7. pmc A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:38-43. 2005
  8. ncbi request reprint Trends in economic consequences of rheumatoid arthritis over two subsequent years
    S M M Verstappen
    University Medical Center Utrecht, The Netherlands
    Rheumatology (Oxford) 46:968-74. 2007
  9. pmc Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    S M M Verstappen
    University Medical Center Utrecht, Utrecht, The Netherlands
    Ann Rheum Dis 66:1443-9. 2007
  10. pmc Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
    M F Bakker
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:iii56-60. 2007

Detail Information

Publications14

  1. ncbi request reprint The Utrecht experience with different treatment strategies in early rheumatoid arthritis
    S M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Clin Exp Rheumatol 21:S165-8. 2003
    ..We therefore conclude that MTX is the DMARD of first choice and that treatment should be tailored to the individual patient...
  2. pmc Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands
    Arthritis Res Ther 8:R31. 2006
    ....
  3. pmc Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:1754-60. 2005
    ..To assess productivity costs incurred by rheumatoid arthritis, comprising paid as well as household productivity costs, from a societal perspective, using different methods...
  4. ncbi request reprint Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Rheumatology (Oxford) 44:202-6. 2005
    ..To assess work disability and variables associated with work disability among Dutch patients with rheumatoid arthritis (RA)...
  5. pmc Determinants of direct costs in Dutch rheumatoid arthritis patients
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 63:817-24. 2004
    ....
  6. ncbi request reprint Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands
    Arthritis Rheum 51:488-97. 2004
  7. pmc A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
    S M M Verstappen
    University Medical Centre Utrecht, Department of Rheumatology and Clinical Immunology, PO Box 85500, 3508 GA Utrecht, Netherlands
    Ann Rheum Dis 64:38-43. 2005
    ..To describe the frequency and duration of remission in the Utrecht rheumatoid arthritis cohort of patients followed since diagnosis, and the clinical and treatment characteristics of patients with remission v those without...
  8. ncbi request reprint Trends in economic consequences of rheumatoid arthritis over two subsequent years
    S M M Verstappen
    University Medical Center Utrecht, The Netherlands
    Rheumatology (Oxford) 46:968-74. 2007
    ..To examine changes in direct costs and in working status over 2 yrs in patients with rheumatoid arthritis (RA)...
  9. pmc Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    S M M Verstappen
    University Medical Center Utrecht, Utrecht, The Netherlands
    Ann Rheum Dis 66:1443-9. 2007
    ..To investigate whether intensive treatment with methotrexate (MTX) according to a strict protocol and a computerised decision program is more beneficial compared to conventional treatment with MTX in early rheumatoid arthritis...
  10. pmc Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
    M F Bakker
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:iii56-60. 2007
    ..Tight control is a treatment strategy tailored to the individual patient with RA, which aims to achieve a predefined level of low disease activity or remission within a certain period of time...
  11. pmc Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 66:727-31. 2007
    ..To compare utility and disease-specific direct costs between patients with ankylosing spondylitis (AS) and patients with rheumatoid arthritis (RA) in the Netherlands...
  12. pmc Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy
    S M M Verstappen
    Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 65:1506-11. 2006
    ....
  13. doi request reprint Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study
    S M M Verstappen
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, F02 127, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 69:1044-8. 2010
    ....
  14. doi request reprint Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
    J N Hoes
    University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, 3508 GA Utrecht, The Netherlands
    Ann Rheum Dis 68:1833-8. 2009
    ..To systematically analyse the literature on reported adverse events of low- to medium-dose glucocorticoids during >or=1 month for inflammatory diseases...